Showing posts with label survival rates. Show all posts
Showing posts with label survival rates. Show all posts

Monday, January 23, 2012

Astronauts undergo Survival Training

It's much colder this week in Star City for Nemo, Canadian astronaut @Astro_Jeremy & Ivan!

Saturday, June 12, 2010

Extreme Life on Earth Could Survive on Mars

Extreme Life on Earth Could Survive on Mars, Too


The Lost Hammer Spring on Axel Heiberg Island, Nunavut Territory, Canada, may be even more inhospitable than some places on Mars. Yet it hosts microbial life, scientists found. Credit: Dept. of Microbiology, McGill University, Montreal

A new discovery of bacterial life in a Martian-like environment on Earth suggests our neighboring red planet could also be hospitable to some form of microbial life.

Researchers found methane-eating bacteria that appear to be thriving in a unique spring called Lost Hammer on Axel Heiberg Island in the extreme north of Canada.

This spring is similar to possible past or present springs on Mars, the scientists say, so it hints that microbial life could potentially exist there, too. There is no firm evidence that Mars does or ever did host life, however.

The Lost Hammer spring is extremely salty – so much so that the water doesn't freeze, even though temperatures are below freezing. The water has no consumable oxygen in it, but there are big bubbles of methane that rise to the surface.

Tuesday, March 16, 2010

RTOG and Highly-focused stereotactic body radiation therapy (SBRT)

Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early findings of a Radiation Therapy Oncology Group (RTOG) study published in the March, cancer-themed, issue of the Journal of the American Medical Association.

Stereotactic body radiation therapy (SBRT) is a noninvasive cancer treatment in which numerous small, highly focused, and accurate radiation beams are used to deliver potent doses in 1 to 5 treatments to tumour targets.

"The primary finding and perhaps most exciting aspect to this prospective study was the high rate of primary tumour control (97.6 percent at 3 years). Primary tumour control is an essential requirement for the cure of lung cancer.

Stereotactic body radiation therapy as delivered in RTOG 0236 provided more than double the rate of primary tumour control previous reported for conventional radiotherapy suggesting that this technique could provide a significant step forward in the battle against this type of lung cancer," said Robert Timmerman, MD, of the University of Texas Southwestern Medical Center, Dallas, principal investigator on the RTOG study.

Currently, patients with inoperable early stage lung cancer are generally offered conventional radiation treatment (most commonly given during 20-30 outpatient treatments) or observed without specific cancer therapy. However, study authors indicate that neither of these approaches achieves ideal outcomes.